文章引用说明 更多>> (返回到该文章)

Yamagami, H., Sakai, N., Matsumaru, Y., Sakai, C., Kai, Y., Sugiu, K., et al. ( 2012) Periprocedural cilostazol trcayment and restenosis after carotid artery stenting: The Retrospective Study of In-Stent Restenosis after Carotid Artery Stenting (ReSISteR-CAS). Journal of Stroke and Cerebrovascular Diseases, 21, 193-199.
http://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2010.06.007

被以下文章引用:

  • 标题: 阿司匹林与氯吡格雷抗血小板凝聚不良反应临床分析To Analyze the Adverse Drug Reaction of Asprin and Clopidogrel during the Treatment for Platelet Aggregation

    作者: 黄之训, 张惠芳, 沈筱云, 周陶然, 钱石静

    关键字: 阿司匹林, 氯吡格雷, 不良反应, 分析Aspirin, Clopidogrel, Adverse Drug Reaction, Analysis

    期刊名称: 《Medical Diagnosis》, Vol.5 No.3, 2015-09-07

    摘要: 目的:分析阿司匹林、氯吡格雷在抗血小板聚集治疗中的ADR及影响ADR结果的危险因素,为临床用药提供参考。方法:以2009-2012年上海ADR中心数据库阿司匹林和氯吡格雷病例为基数,通过年龄或单抗和双抗治疗随机分组进行回顾性分析,以报告类型、严重程度、原患疾病、用药原因、ADR致器官损害、ADR起始发病日、ADR结果作为观察指标,使用SPSS软件进行分析。结果:单抗和双抗两组基线特征比较差异无统计学意义(p> 0.05)。两组观察指标相关性检查及单因素独立危险因素比较,严重程度、出血、ADR结果和ADR最初阶段发病p Objective: To analyze the adverse drug reaction and their risk factors of Aspirin and Clopidogrel during the treatment for platelet aggregation, providing reference for clinical medication. Methods: Based on 2009-2012 database of Shanghai ADRs center, ADR cases about Aspirin and Clopidogrel were analyzed retrospectively through age groups or randomized by combination and independence for retrospective analysis. Also the types of reports, severity of diseases, the original disease, the reason of medication, organ damage by ADR, as well as the initial period and results of ADRs were applied as the observation indexes and were analyzed by using the SPSS software. Results: In the groups of combination and independence, their p value of baseline characteristics was above 0.05 (p > 0.05), which indicated no statistical significance. In contrast, p values of observation index correlation test, report types, severity, bleeding part, ADR results and the initial period of ADR were below the level of 0.05 (p p

在线客服:
对外合作:
联系方式:400-6379-560
投诉建议:feedback@hanspub.org
客服号

人工客服,优惠资讯,稿件咨询
公众号

科技前沿与学术知识分享